Department of Clinical Neurosciences
Since 1981 we have grown rapidly to become a national leader in research, medical education and patient care in the neurosciences. From the world's most sophisticated intra-operative imaging technologies to the first robot for micro-neurosurgical application, we continue to explore the boundaries of the clinical neurosciences. Recruited from around the world, our expert and research-intensive team of neurologists, neurosurgeons, physiatrists and researchers provide exemplary care to residents of southern Alberta and beyond.
The Department of Clinical Neurosciences is celebrating its participation in one of Brain Canada’s Platform Support Grants, which were unveiled today in Toronto.
Clinical Neurosciences is partnering with the Rick Hansen Institute and the Alberta Paraplegic Foundation to build the Rick Hansen Alberta Spinal Cord Injury Registry
The $900,000, three-year project, which is led by the Division of Physical Medicine & Rehabilitation’s Dr. Chester Ho, is designed to expand on the success of the Vancouver-based institute’s current registry and build a model that be replicated across Canada.
“I am very honoured to have the opportunity to collaborate with multiple partners in Alberta and the Rick Hansen Institute to develop this registry,” said Dr. Ho.
I am very pleased to introduce Dr. Oury Monchi to our department. Dr. Oury Monchi has been appointed Professor (with tenure) in the departments of Clinical Neurosciences and Radiology, and at the Hotchkiss Brain Institute.
Dr. Monchi will serve the department as Clinical Research Director, and the department, HBI and the Cumming School of Medicine as the Research Director of the Movement Disorders Program, and the Tourmaline Oil Chair in Parkinson’s disease.
Dr. Monchi obtained his PhD in computational Neuroscience at King's College London, University of London, UK. He then pursued a postdoctoral fellowship at the Montreal Neurological Institute and the Centre de Recherche de l'institut Universitaire de Gériatrie de Montréal in neuroimaging and cognitive neuroscience applied to Parkinson's disease.
Until the summer 2014 he was Associate Professor of Radiology at the Université de Montréal and Associate Director for Clinical Research at the CRIUGM. He was also the founding director of the Quebec Parkinson's Network.
Dr. Monchi's lab has been a pioneer in using different neuroimaging techniques to study the origins and evolution of cognitive deficits in Parkinson's disease with the ultimate goal of the early prediction of dementia in the disease. Interactions between cognitive and neuropsychiatric symptoms are also being studied. Non-medication therapies such as transcranial magnetic stimulation and cognitive training are also being explored. Methods used include functional and anatomical MRI, TMS, PET, neuropsychological evaluations, and genotyping.
Please join me in warmly welcoming Dr. Monchi to DCNS.
Dr. Rajiv Midha
Head, Department of Clinical Neurosciences